A 28-year-old man with systemic lupus erythematosus develops nephrotic syndrome. Kidney biopsy shows wire-loop lesions and subendothelial immune deposits. Which single feature best distinguishes lupus nephritis (Class IV) from membranoproliferative glomerulonephritis in a patient with nephrotic presentation?

Explanation

## Distinguishing Lupus Nephritis from MPGN ### Clinical and Serological Discrimination **Key Point:** While both lupus nephritis and MPGN can present with nephrotic syndrome and show immune complex deposition, the combination of low serum complement (C3, C4) with positive ANA is virtually pathognomonic for lupus nephritis and absent in primary MPGN. ### Comparative Table | Feature | Lupus Nephritis (Class IV) | MPGN | | --- | --- | --- | | **ANA** | Positive (>95%) | Negative | | **Anti-dsDNA** | Positive (highly specific) | Negative | | **Serum C3/C4** | Low (immune complex consumption) | Normal or mildly low | | **Light Microscopy** | Wire-loop, subendothelial deposits | Endocapillary or membranoproliferative pattern | | **EM Deposits** | Subendothelial, intramembranous, subepithelial | Subendothelial (MPGN-I) or intramembranous (MPGN-II) | | **Clinical Context** | Systemic manifestations (rash, arthritis, APS) | Isolated renal disease or secondary (HCV, C3GN) | | **Crescent Formation** | May occur in Class IV-G | Less common in primary MPGN | ### Why Serology Discriminates Best **High-Yield:** Serum complement levels and ANA/anti-dsDNA are non-invasive, readily available tests that distinguish lupus nephritis from MPGN before or alongside biopsy. Low C3/C4 with positive ANA is the gold standard for lupus diagnosis. **Mnemonic:** **SLAM** — Serum complement Low, ANA/anti-dsDNA positive, Manifestations systemic (rash, arthritis, serositis) = Lupus. MPGN has none of these. ### Pathophysiology **Lupus Nephritis:** 1. Circulating immune complexes (anti-dsDNA + dsDNA) 2. Complement activation (classical pathway) → C3, C4 consumption 3. Deposition in all three compartments (subendothelial, intramembranous, subepithelial) 4. Wire-loop lesions = subendothelial immune complex deposits **MPGN:** 1. Immune complex (secondary forms) or complement-mediated (C3GN) 2. Complement activation variable 3. Primarily subendothelial deposits 4. No systemic autoimmune features ### Clinical Pearl Lupus nephritis occurs in ~50% of SLE patients and is a major cause of morbidity. The presence of low C3/C4 correlates with active lupus nephritis and is used to monitor disease activity. MPGN, by contrast, is often idiopathic or secondary to HCV/HBV and lacks the serological signature of lupus. [cite:Harrison 21e Ch 297]